With his term winding down, Federal Reserve Chair Jerome Powell offered rare, pointed advice to his eventual successor during a recent press conference, emphasizing the imperative of maintaining the central bank's independence from political influence.
In a turbulent session driven by geopolitical fears, gold staged a historic V-shaped recovery while Bitcoin languished, raising fresh questions about the cryptocurrency's viability as a modern safe haven.
MicroStrategy has added nearly 3,000 Bitcoins to its corporate treasury, solidifying its lead as the largest public holder of the cryptocurrency. The purchase, funded by new stock sales, intensifies the debate over the company's valuation and the risks of its aggressive Bitcoin accumulation strategy.
Regeneron Pharmaceuticals' shares have softened in recent weeks, lagging behind broader market gains. A deep dive into valuation metrics, including DCF analysis and P/E ratios, suggests the biotech giant may be significantly undervalued. We examine the numbers behind the headlines and what they mean for investors.
While buying the dip can be a profitable strategy, investors should steer clear of C3.ai and The Trade Desk. Significant operational challenges and management turmoil suggest their recent plunges may not be over.
A new analysis reveals auto insurance rate hikes in Nevada are slowing dramatically for 2026, though the state remains the nation's most expensive market. Experts point to stabilizing claim costs and urge drivers to shop around for significant savings.
As financial institutions worldwide grapple with sluggish, fragmented payment systems, fintech firm Alacriti is gaining traction by offering a pragmatic path to modernization—not through disruption, but by building essential infrastructure.
Klarna Group confronts a wave of class action lawsuits alleging it downplayed rising loan loss risks in its buy-now-pay-later portfolio ahead of its 2025 NYSE debut. The legal challenges cast a shadow over the fintech's post-IPO performance and have sparked a broader debate about transparency in the rapidly growing BNPL sector.
As Uranium Royalty Corp. (TSX:URC) prepares to present at the Vancouver Resource Investment Conference, investors are grappling with a stark valuation paradox: a sky-high price-to-sales ratio suggests overvaluation, while a discounted cash flow model points to significant upside. The company's recent share price surge adds momentum to the debate.
Shares of gaming and hospitality REIT VICI Properties have faced recent headwinds, trading near $28 and presenting a significant discount to analyst targets. We examine whether the current valuation gap signals a buying opportunity or reflects deeper sectoral risks.
Apple's fiscal Q1 2026 results, fueled by "staggering" demand for the iPhone 17, delivered record revenue and a dramatic turnaround in China, silencing critics and reigniting growth.
The new year brings a fresh wave of airline failures as Ecojet, a UK-based startup aiming to be the world's first zero-emission carrier, enters voluntary liquidation. Its collapse follows recent shutdowns in the Philippines and India, highlighting persistent turbulence in the regional aviation sector.
A significant divestment from a short-duration bond ETF highlights a broader portfolio pivot towards growth assets as opportunity costs rise, questioning the role of capital preservation funds in a changing rate environment.
Newly filed state documents reveal the geographic breakdown of Amazon's latest workforce reduction in Washington, with T-Mobile and International Paper also submitting layoff notices affecting hundreds more employees across the state.
Two Stanford graduate students have raised $2 million to launch Breakthrough Ventures, a nationwide accelerator designed to fund and mentor student-founded companies, addressing the historic lack of capital and networks for young entrepreneurs.
A severe, AI-driven shortage of memory chips is creating a windfall for storage manufacturers, with analysts predicting a multi-year upcycle as data center demand overwhelms supply.
A 25-year-old Johnstown woman faces 18 felony counts, including arson endangering lives, after investigators say she intentionally set a duplex fire that forced residents to leap from second-story windows to escape.
TD Cowen and H.C. Wainwright have raised price targets on KalVista Pharmaceuticals, expressing confidence in its oral hereditary angioedema treatment ahead of the company's fourth-quarter financial results.
Bernstein analyst lifts ASML's price target to $1,911, citing a buying opportunity after recent pullback. The chip equipment giant's record Q4 orders and updated guidance signal confidence in the AI-driven semiconductor upcycle.
Oppenheimer upgrades Relay Therapeutics (RLAY) to Outperform, citing the strength of its mutant-selective inhibitor pipeline and upcoming catalysts in the breast cancer treatment arena.
